Technical Specifications

Product name:
FROTH
-
PAK
™
650BF HFC CLASS A POLYOL
Spray Polyurethane Foam
Issue Date:
07/29/2014
Page 3 of 19
4. FIRST AID MEASURES
Description of first aid measures
General advice: First Aid responders should pay attention to self-protection and use the
recommended protective clothing (chemical resistant gloves, splash protection). If potential for
exposure exists refer to Section 8 for specific personal protective equipment.
Inhalation: Move person to fresh air. If not breathing, give artificial respiration; if by mouth to mouth
use rescuer protection (pocket mask, etc). If breathing is difficult, oxygen should be administered by
qualified personnel. Call a physician or transport to a medical facility.
Skin contact: Wash off with plenty of water.
Eye contact: Flush eyes thoroughly with water for several minutes. Remove contact lenses after the
initial 1-2 minutes and continue flushing for several additional minutes. If effects occur, consult a
physician, preferably an ophthalmologist. Suitable emergency eye wash facility should be available in
work area.
Ingestion: Do not induce vomiting. Call a physician and/or transport to emergency facility
immediately.
Most important symptoms and effects, both acute and delayed: Aside from the information found
under Description of first aid measures (above) and Indication of immediate medical attention and
special treatment needed (below), any additional important symptoms and effects are described in
Section 11: Toxicology Information.
Indication of any immediate medical attention and special treatment needed
Notes to physician: Due to structural analogy and clinical data, this material may have a mechanism
of intoxication similar to ethylene glycol. On that basis, treatment similar to ethylene glycol intoxication
may be of benefit. In cases where several ounces (60 - 100 ml) have been ingested, consider the use
of ethanol and hemodialysis in the treatment. Consult standard literature for details of treatment. If
ethanol is used, a therapeutically effective blood concentration in the range of 100 - 150 mg/dl may be
achieved by a rapid loading dose followed by a continuous intravenous infusion. Consult standard
literature for details of treatment. 4-Methyl pyrazole (Antizol®) is an effective blocker of alcohol
dehydrogenase and should be used in the treatment of ethylene glycol (EG), di- or triethylene glycol
(DEG, TEG), ethylene glycol butyl ether (EGBE), or methanol intoxication if available. Fomepizole
protocol (Brent, J. et al., New England Journal of Medicine, Feb. 8, 2001, 344:6, p. 424-9): loading
dose 15 mg/kg intravenously, follow by bolus dose of 10 mg/kg every 12 hours; after 48 hours,
increase bolus dose to 15 mg/kg every 12 hours. Continue fomepizole until serum methanol, EG,
DEG, TEG or EGBE are undetectable. The signs and symptoms of poisoning include anion gap
metabolic acidosis, CNS depression, renal tubular injury, and possible late stage cranial nerve
involvement. Respiratory symptoms, including pulmonary edema, may be delayed. Persons receiving
significant exposure should be observed 24-48 hours for signs of respiratory distress. In severe
poisoning, respiratory support with mechanical ventilation and positive end expiratory pressure may be
required. Maintain adequate ventilation and oxygenation of the patient. Attempt seizure control with
diazepam 5-10 mg (adults) intravenous over 2-3 minutes. Repeat every 5-10 minutes as needed.
Monitor for hypotension, respiratory depression, and need for intubation. Consider second agent if
seizures persist after 30 mg. If seizures persist or recur administer phenobarbital 600-1200 mg
(adults) intravenous diluted in 60 ml 0.9% saline given at 25-50 mg/minute. Evaluate for hypoxia,
dysrhythmia, electrolyte disturbance, hypoglycemia (treat adults with dextrose 100 mg intravenous). If
lavage is performed, suggest endotracheal and/or esophageal control. Danger from lung aspiration
must be weighed against toxicity when considering emptying the stomach. Exposure may increase
“myocardial irritability”. Do not administer sympathomimetic drugs such as epinephrine unless